NasdaqCM - Nasdaq Real Time Price USD

Conduit Pharmaceuticals Inc. (CDTTW)

0.0098
+0.0004
+(4.26%)
At close: May 20 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
16,173
15,119
5,262
3,160
3,173
Operating Income
-16,173
-15,119
-5,262
-3,160
-3,173
Net Non Operating Interest Income Expense
-1,551
-1,493
-196
0
--
Other Income Expense
-1,682
-1,200
8,300
-1,727
-484
Pretax Income
-19,406
-17,812
2,842
-4,887
-3,657
Net Income Common Stockholders
-19,396
-17,802
-535
-4,887
-3,657
Average Dilution Earnings
--
0
-5,521
--
--
Diluted NI Available to Com Stockholders
-19,396
-17,802
-6,056
-4,887
-3,657
Total Operating Income as Reported
-16,473
-15,419
-5,262
-3,160
-3,173
Total Expenses
16,173
15,119
5,262
3,160
3,173
Net Income from Continuing & Discontinued Operation
-19,396
-17,802
-535
-4,887
-3,657
Normalized Income
-17,842
-17,302
-5,986
-3,425
-3,246
Interest Income
12
13
15
0
--
Interest Expense
1,563
1,506
211
0
--
Net Interest Income
-1,551
-1,493
-196
0
--
EBIT
-17,843
-16,306
3,053
-4,887
-3,173
EBITDA
-17,196
-15,849
3,053
-4,887
-3,173
Reconciled Depreciation
647
457
0
--
--
Net Income from Continuing Operation Net Minority Interest
-19,396
-17,802
-535
-4,887
-3,657
Total Unusual Items Excluding Goodwill
-1,554
-500
6,900
-1,462
-411
Total Unusual Items
-1,554
-500
6,900
-1,462
-411
Normalized EBITDA
-15,642
-15,349
-3,847
-3,425
-2,762
Tax Rate for Calcs
0
0
0.0002
0
0
Tax Effect of Unusual Items
0
0
1,449
0
0
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

APLMW Apollomics, Inc.
0.0150
+0.67%
 
NLSPW NLS Pharmaceutics AG
0.0179
+326.19%
 
TCBWF TC Biopharm (Holdings) Plc
0.0080
-10.11%
 
ESLAW Estrella Immunopharma, Inc.
0.0425
-22.73%
 
SLXNW Silexion Therapeutics Corp
0.0412
-0.24%
 
TVGNW Tevogen Bio Holdings Inc.
0.0469
-6.20%
 
COEPW Coeptis Therapeutics Holdings, Inc.
0.0323
+0.31%
 
DRMAW Dermata Therapeutics, Inc.
0.0137
-44.98%
 
LIXTW Lixte Biotechnology Holdings, Inc.
0.0392
+51.94%
 
GOVXW GeoVax Labs, Inc.
0.0436
0.00%